ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 293 filers reported holding ROIVANT SCIENCES LTD in Q2 2024. The put-call ratio across all filers is 1.17 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,089,611 | -4.4% | 292,300 | -4.7% | 0.02% | -5.0% |
| Q1 2024 | $3,232,618 | +1.7% | 306,700 | +8.3% | 0.02% | -9.1% |
| Q4 2023 | $3,178,988 | -2.1% | 283,080 | +1.8% | 0.02% | -12.0% |
| Q3 2023 | $3,246,806 | +26.5% | 277,980 | +9.2% | 0.02% | +31.6% |
| Q2 2023 | $2,566,166 | +67.9% | 254,580 | +22.9% | 0.02% | +58.3% |
| Q1 2023 | $1,528,398 | – | 207,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $703,226,471 | 59.48% |
| Patient Square Capital LP | 12,228,465 | $128,888,021 | 54.89% |
| Two Seas Capital LP | 7,930,349 | $83,585,878 | 16.37% |
| Whitefort Capital Management, LP | 2,391,000 | $25,201,140 | 15.35% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $50,936,047 | 13.26% |
| BlackBarn Capital Partners LP | 1,900,594 | $20,032,261 | 11.32% |
| Tejara Capital Ltd | 2,600,295 | $27,407,109 | 10.07% |
| STEMPOINT CAPITAL LP | 3,553,844 | $37,457,516 | 9.90% |
| Tyro Capital Management LLC | 1,495,594 | $15,763,561 | 9.10% |
| SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $769,753,770 | 7.60% |